Item 7. Management’s Discussion and Analysis
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Management’s Discussion and Analysis
of Financial Condition and Results of Operations contain certain forward-looking statements. Historical results may not indicate future
performance. Our forward-looking statements reflect our current views about future events; are based on assumptions and are subject to
known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements.
We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any
facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee
future results, events, levels of activity, performance, or achievements.
Basis of Presentation
The financial information presented below
and the following Management Discussion and Analysis of the Consolidated Financial Condition, Results of Operations,
Stockholders’ Equity and Cash Flow for the periods ended December 31, 2023 and 2022 gives effect to our acquisition of OXYS
Corporation (“ OXYS ”) on July 28, 2017 and HereLab, Inc. In accordance with the accounting reporting requirements
for the recapitalization related to the “reverse merger” of OXYS, the consolidated financial statements for OXYS have
been adjusted to reflect the change in the shares outstanding and the par value of the common stock of OXYS. Additionally, all
intercompany transactions between the Company and its subsidiaries have been eliminated.
11
Forward-Looking Statements
Statements in this management’s discussion
and analysis of financial condition and results of operations contain certain forward-looking statements. To the extent that such statements
are not recitations of historical fact, such statements constitute forward-looking statements which, by definition involve risks and uncertainties.
Where in any forward-looking statements, if we express an expectation or belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation or
belief will result or be achieved or accomplished.
Factors that may cause differences between actual
results and those contemplated by forward-looking statements are not limited to the following:
·
the unprecedented impact of COVID-19 pandemic on our business, customers, employees, subcontractors and supply chain, consultants, service providers, stockholders, investors and other stakeholders;
·
the impact of conflict between the Russian Federation and Ukraine on our operations;
·
geo-political events, such as the crisis in Ukraine, government responses to such events and the related impact on the economy both nationally and internationally;
·
general market and economic conditions;
·
our ability to maintain and grow our business with our current customers;
·
our ability to meet the volume and service requirements of our customers;
·
industry consolidation, including acquisitions by us or our competitors;
·
capacity utilization and the efficiency of manufacturing operations;
·
success in developing new products;
·
timing of our new product introductions;
·
new product introductions by competitors;
·
the ability of competitors to more fully leverage low-cost geographies for manufacturing or distribution;
·
product pricing, including the impact of currency exchange rates;
·
effectiveness of sales and marketing resources and strategies;
·
adequate manufacturing capacity and supply of components and materials;
·
strategic relationships with our suppliers;
·
product quality and performance;
·
protection of our products and brand by effective use of intellectual property laws;
·
the financial strength of our competitors;
·
the outcome of any future litigation or commercial dispute;
·
barriers to entry imposed by competitors with significant market power in new markets;
·
government actions throughout the world; and
·
our ability to service secured debt, when due.
You should not rely on forward-looking statements
in this document. This management discussion contains forward looking statements that involve risks and uncertainties. We use words such
as “anticipates,” “believes,” “plans,” “expects,” “future,” “intends,”
and similar expressions to identify these forward-looking statements. Prospective investors should not place undue reliance on these statements,
which apply only as of the date of this document. Our actual results could differ materially from those anticipated in these forward-looking
statements.
12
Critical Accounting Policies
The following discussions are based upon our financial
statements, which have been prepared in accordance with accounting principles generally accepted in the United States. These financial
statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States.
The preparation of these financial statements
requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and
expenses, and related disclosures of contingencies. We continually evaluate the accounting policies and estimates used to prepare financial
statements. We base our estimates on historical experiences and assumptions believed to be reasonable under current facts and circumstances.
Actual amounts and results could differ from these estimates made by management.
Historical Background
We were incorporated in the State of New Jersey
on October 1, 2003 under the name of Creative Beauty Supply of New Jersey Corporation and subsequently changed our name to Gotham Capital
Holdings, Inc. on May 18, 2015. We commenced operations in the beauty supply industry as of January 1, 2004. On November 30, 2007, our
Board of Directors approved a plan to dispose of our wholesale and retail beauty supply business. From January 1, 2009 until July 28,
2017, we had no operations and were a shell company.
On March 16, 2017, our Board of Directors adopted
resolutions, which were approved by shareholders holding a majority of our outstanding shares, to change our name to “IIOT-OXYS,
Inc.”, to authorize a change of domicile from New Jersey to Nevada, to authorize a 2017 Stock Awards Plan, and to approve the Securities
Exchange Agreement (the “ OXYS SEA ”) between the Company and OXYS Corporation (“ OXYS ”), a Nevada
corporation incorporated on August 4, 2016.
Under the terms of the OXYS SEA we acquired 100%
of the issued voting shares of OXYS in exchange for 34,687,244 shares of our Common Stock. We also cancelled 1,500,000 outstanding shares
of our Common Stock and changed our management to Mr. DiBiase who also served in the management of OXYS. Also, one of our principal shareholders
entered into a consulting agreement with OXYS to provide consulting services during the transition. The OXYS SEA was effective on July
28, 2017, and our name was changed to “IIOT-OXYS, Inc.” at that time. Effective October 26, 2017, our domicile was changed
from New Jersey to Nevada.
At the present time, we have two wholly owned
subsidiaries which are OXYS Corporation and HereLab, Inc. (an entity immaterial to our operations), through which our operations are conducted.
General Overview
IIOT-OXYS, Inc., a Nevada corporation (the “ Company ”),
and OXYS, were originally established for the purposes of designing, building, testing, and selling Edge Computing systems for the Industrial
Internet. Both companies were, and presently are, early-stage technology startups that are largely pre-revenue in their development
phase. HereLab is also an early-stage technology development company. We received our first revenues in the last quarter
of 2017, continued to realize revenues until 2020 when the pandemic hit, and we realized nominal revenues through 2021 to the present.
13
We develop hardware, software and algorithms that
monitor, measure and predict conditions for energy, structural, agricultural and medical applications. We use domain-specific Artificial
Intelligence to solve industrial and environmental challenges. Our engineered solutions focus on common sense approaches to machine learning,
algorithm development and hardware and software products.
We use off the shelf components, with reconfigurable
hardware architecture that adapts to a wide range of customer needs and applications. We use open-source software tools, while still creating
proprietary content for customers, thereby reducing software development time and cost. The software works with the hardware to collect
data from the equipment or structure that is being monitored.
We focus on developing insights. We develop algorithms
that help our customers create insights from vast data streams. The data collected is analyzed and reports are created for the customer.
From these insights, the customer can act to improve their process, product or structure.
Results of Operations for the Year Ended
December 31, 2023 compared to the year ended December 31, 2022
For
the year ended December 31, 2023, we earned revenues of $114,666 and incurred related cost of sales of $76,645. Our operating expenses
were $731,430 which included professional fees of $172,704, payroll costs of $244,083, amortization of intangible assets of $49,500, bad
debts of $215,069 and other general and administrative expenses of $51,029. We recorded net other expenses of $374,530 consisting of a
loss of $185,973 due to debt extinguishment on notes payable
due to change in conversion price, interest income on note receivable of $25,969, offset by interest expense of $210,426 and loss on change
in fair market value of derivative liability of $4,100. We also recorded $68,531 as preferred stock dividend on convertible preferred
stock for the year ended December 31, 2023. As a result, we incurred a net loss of $1,136,460 for
the year ended December 31, 2023.
For the year ended December 31, 2022, we earned
revenues of $88,904 and incurred related cost of sales of $10,499. Our operating expenses were $733,071 which included professional fees
of $268,837, payroll costs of $373,774, amortization of intangible assets of $49,500, and general and administrative expenses of $40,960.
We recorded net other expenses of $369,560 consisting of recording loss on derivatives of $200,519, interest expense of $377,138 offset
by gain on change in fair market value of derivative liability of $190,462 and interest income on note receivable of $17,634. We also
recorded $52,654 as preferred stock dividend on convertible preferred stock for the year ended December 31, 2022. As a result, we incurred
a net loss of $1,076,881 for the year ended December 31, 2022.
During the current and prior year, we did not
record an income tax benefit due to the uncertainty associated with the Company’s ability to utilize the deferred tax assets.
Revenues earned in 2023 were a substantial improvement
over the same period in 2022 (an increase of 29%). We expect revenue to moderate in 2024, as our ability to raise funding to fuel sales
& marketing efforts has been limited. Potential future revenue growth is possible, pending adequate funding for sales and marketing
efforts and building on the strength of the following factors:
·
Our current DOT Bridge Monitoring Contract and overall Structural Health Monitoring (“ SHM ”) vertical is the foundation of our revenue stream. Discussions with our main contractor to the DOT for extensions and expansions continue to be favorable. We also continue to believe that prospects with our current DOT state, and DOT contacts in two other northeast states bode well for future business in mid-2024. There is still potential for local municipalities in our current northeast state to contribute revenue in 2024.
·
Our Smart Manufacturing vertical is benefiting from the progress on our CNC SaaS contract that commenced in June 2023 and continued through the fourth quarter of 2023. In February 2024, we renewed our CNC SaaS contract with our current customer. Initial public endorsements and promotional videos have been released and additional videos are planned for release in the third quarter of 2024. These endorsements and promotional videos along with grass-roots sales & marketing efforts have generated additional sales leads for potential paid CNC POCs and additional SaaS contracts, which may contribute to revenue in the third quarter of 2024 and beyond. It is also expected these endorsements will also strengthen our position to secure additional POCs for other discrete manufacturing processes, including metal stamping, plastic injection molding, plastic extrusion, and automated assembly and test.
14
·
Our strategic partnership development continues to be a “force multiplier” for us. The strength of our Aingura IIoT, S.L. partnership provides supplemental expertise, equipment and software, which ensures we continue to bring value to our customers. We will also continue to develop our other previously announced partnerships.
Despite these strengths, we continue to face significant
headwinds and we have not been able to raise material funds for ongoing operations through our existing financing agreements due to market
conditions. Our CEO and COO have not received any compensation since mid-April (their salaries have accrued), and the lack of funds has
severely limited sales and marketing efforts. Our management is working to secure funding from our lead investor to pay for ongoing expenses
and the leadership team is considering its options for both the short and long term. Given the current challenges in raising adequate
funds, management is pursuing options including vetting suitable companies to merge with or acquire us.
We believe we’ve created substantial value
from our business development in these industries, which have potential for success, due to the strength of their size and growth. The
global smart manufacturing (also known as Industry 4.0) was $108.9 billion in 2023 and will reach $241 billion by 2028 (CAGR 17.2%), 1
and the worldwide SHM industry is $2.5 billion in 2024 and will reach $4.1 billion by 2029 (CAGR of 10.4%). 2
Given the valuable real-world data we have collected,
our Artificial Intelligence (“AI”) Machine Learning algorithms we have developed, compelling use cases and marketing collateral
developed from our data and algorithms, combined with our experienced leadership, savvy technological talent, and prudent operational
execution, we believe our company’s assets have potential continued annual revenue growth, that will be attractive to prospective
partners interested in an acquisition or merger.
Liquidity and Capital Resources for the
Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022
As of December 31, 2023, we reported a cash
balance of $644 as a result of decrease of $32,692 from the $33,336 cash balance at December 31, 2022. This decrease was primarily
as a result of net cash used in operating activities of $146,564 and net cash provided by financing activities of $113,872.
Operating Activities
Net cash flows used in operating activities for
the year ended December 31, 2023 was $146,564, primarily attributed to the net loss of $1,136,460, stock compensation expense of $4,665,
bad debts of $214,103, amortization of debt discount on notes payable and preferred stock of $12,400, amortization of intangible assets
of $49,500 and loss on extinguishment of notes payable of $186,294. The Company recorded changes in operating assets and liabilities of
$522,935 primarily attributable to decrease in accounts receivable of $4,662 due to collections from customers, decrease in prepaid expenses
and other current assets of $5,467, increase in accounts payable of $86,145 due to negotiating longer payment terms, increase in accrued
liabilities of $248,368 due to non-payment of additional interest accrued on notes payable, increase in derivative liabilities due to
the change in the fair value of derivative liabilities of $65,779, decrease in unearned interest of $5,151, increase in shares payable
to related parties of $601, and increase in salaries payable to related parties of $117,063.
Net cash flows used in operating activities for
the year ended December 31, 2022 was $657,009, primarily attributable to net loss of $1,076,881, stock compensation expense of $900, discount
on note receivable of $4,719, and amortization of intangible assets of $49,500. The Company recorded a net change in operating assets
and liabilities of $364,756 attributable to net increase in accounts receivable of $17,661, decrease in accounts payable of $27,763, net
increase in accrued liabilities of $148,558, net increase in derivative liabilities of $267,257, increase in unearned interest of $5,151,
decrease in deferred revenues of $15,000, increase in shares payable to related parties of $14,624, and a net increase in salaries payable
to related parties of $10,410.
__________________________
1
https://www.marketsandmarkets.com/Market-Reports/industry-4-market-102536746.html
2
https://www.marketsandmarkets.com/Market-Reports/structural-health-monitoring-market-101431220.html
15
Investing Activities
Net cash used in investing activities for the
year ended December 31, 2023 was $0. Net cash used in investing activities for the year ended December 31, 2022 resulted due to cash advanced
for a promissory note receivable totaling $200,000.
Financing Activities
Net cash provided by financing activities for
the year ended December 31, 2023 was $113,872 primarily due to sale of our common stock of $51,872 net of costs incurred in capital raise,
and sale of Series B convertible preferred stock of $62,000. Cash provided by financing activities for the year ended December 31, 2022
was $843,524 primarily due to cash received from sale of common stock of $557,065 net of $11,141 cash paid for costs incurred in raising
capital, and cash received from sale of Series B convertible preferred stock of $297,600.
As a result of the above activities, the Company
recorded a decrease in cash of $32,692 for the year ended December 31, 2023, and a decrease in cash of $13,485 for the same comparable
period ended December 31, 2022, respectively.
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As shown in the financial statements, the Company has suffered
continuing operating losses, has a working capital deficit of $2,067,461, used cash flows in operating activities of $146,564, and has
an accumulated deficit of $10,443,597 as of December 31, 2023. These factors, among others, raise substantial doubt about the Company’s
ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
Recently Issued Accounting Standards
Other accounting standards that have been issued
or proposed by FASB and do not require adoption until a future date are not expected to have a material impact on the consolidated financial
statements upon adoption. Management does not believe that any other recently issued, but not yet effective, accounting standard if currently
adopted would have a material effect on the accompanying financial statements.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements
that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources.
Item 7A. Quantitative And Qualitative Disclosures About Market Risk
As a Smaller Reporting Company, we are not required
to furnish information under this Item 7A.
Item 8. Financial Statements
The financial statements and supplementary data
required by this item are included following the signature page of this Annual Report.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
None.
16
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.